SCRI - Tennessee — Nashville, Tennessee

SCRI - Tennessee is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

SCRI - Tennessee has participated in 1 clinical trials.

Therapeutic areas: Solid Tumor, Colorectal Cancer, Non Hodgkin Lymphoma.

Sponsors: IGM Biosciences, Inc..

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI - Tennessee?

SCRI - Tennessee has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI - Tennessee conducted?

SCRI - Tennessee has 1 clinical trials on record. Their work covers Solid Tumor, Colorectal Cancer, Non Hodgkin Lymphoma.

Is SCRI - Tennessee accredited by Crixeo Health?

SCRI - Tennessee has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI - Tennessee?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.